Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3

I Corre1, H Baumann, S Hermouet

  • 1Groupe Cytokines, Récepteurs et Transduction de Signal, INSERM U463, Institut de Biologie, Nantes, France.

Oncogene
|December 22, 1999
PubMed

Insights

Gi2 proteins regulate cell proliferation by controlling Src-kinase and STAT3 activity in response to CSF-1R signaling. Inactivating Gi2 impairs DNA synthesis and transformation, highlighting its critical role in CSF-1R pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Signal Transduction

Background:

  • Gi2 proteins are known to interfere with Colony-Stimulating Factor 1 Receptor (CSF-1R) mediated proliferation signals.
  • Understanding the specific CSF-1R pathways regulated by Gi2 is crucial for deciphering cell growth control mechanisms.

Purpose of the Study:

  • To identify the CSF-1R signaling pathways modulated by Gi2 proteins.
  • To investigate the role of Gi2 in v-fms (oncogenic CSF-1R) induced cell proliferation, transformation, and associated signaling events.

Main Methods:

  • NIH3T3 cells were transfected with v-fms and a dominant-negative mutant of Gi2 alpha subunit (alpha i2-G204A) to inactivate Gi2.
  • Analysis of Src-kinase activity, ERK-MAPK activation, cyclin D1 expression, DNA synthesis, and STAT3 phosphorylation.
  • Expression of truncated STAT3 mutants was assessed.

Main Results:

  • Inactivation of Gi2 reduced Src-kinase activity, delayed ERK-MAPK activation, decreased cyclin D1 expression, and inhibited serum-induced proliferation.
  • While v-fms could bypass Src to activate ERK-MAPK in Gi2-deficient cells, DNA synthesis and focus formation were significantly inhibited (up to 80%).
  • Gi2 inactivation inhibited STAT3 tyrosine phosphorylation and increased expression of a truncated STAT3 delta form, effects mimicked by dominant-negative Src.

Conclusions:

  • Gi2 proteins are essential for optimal cell proliferation in response to CSF-1R/v-fms signaling.
  • Adequate regulation of Src-kinase and STAT3 activity by Gi2 is required for CSF-1R-mediated DNA synthesis and cellular transformation.
  • STAT3 delta, a truncated form, plays a role in inhibiting DNA synthesis and v-fms-induced transformation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...